Zhentong Wei

826 total citations
33 papers, 585 citations indexed

About

Zhentong Wei is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, Zhentong Wei has authored 33 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Biotechnology. Recurrent topics in Zhentong Wei's work include Cancer Cells and Metastasis (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Immunotherapy and Immune Responses (3 papers). Zhentong Wei is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Immunotherapy and Immune Responses (3 papers). Zhentong Wei collaborates with scholars based in China and United States. Zhentong Wei's co-authors include Songling Zhang, Xinxin Ci, Min Xie, Yuting Jiang, Wanying Li, Ning Ma, Wei Wei, Yandong Zhang, Haoran Guo and Chunfeng Wang and has published in prestigious journals such as Journal of Clinical Oncology, Biomaterials and Scientific Reports.

In The Last Decade

Zhentong Wei

31 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhentong Wei China 13 348 118 111 98 83 33 585
Zhaojun Shen China 11 337 1.0× 136 1.2× 163 1.5× 184 1.9× 54 0.7× 16 684
Aki Yamashita Japan 15 199 0.6× 147 1.2× 163 1.5× 129 1.3× 107 1.3× 27 650
Mónica Mendoza-Rodríguez Mexico 12 257 0.7× 97 0.8× 130 1.2× 92 0.9× 13 0.2× 36 502
Qiaoli Zheng China 12 267 0.8× 140 1.2× 85 0.8× 117 1.2× 18 0.2× 30 627
Bing Wei China 19 256 0.7× 218 1.8× 103 0.9× 107 1.1× 125 1.5× 42 755
Woong‐Shick Ahn South Korea 17 342 1.0× 108 0.9× 102 0.9× 65 0.7× 22 0.3× 28 646
Shan‐Chih Lee Taiwan 15 305 0.9× 55 0.5× 132 1.2× 69 0.7× 45 0.5× 43 702
Manhua Cui China 18 591 1.7× 83 0.7× 214 1.9× 212 2.2× 131 1.6× 55 984
Zohreh Hojati Iran 13 443 1.3× 30 0.3× 125 1.1× 141 1.4× 22 0.3× 71 706
Buzhen Tan China 14 289 0.8× 48 0.4× 39 0.4× 133 1.4× 88 1.1× 21 535

Countries citing papers authored by Zhentong Wei

Since Specialization
Citations

This map shows the geographic impact of Zhentong Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhentong Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhentong Wei more than expected).

Fields of papers citing papers by Zhentong Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhentong Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhentong Wei. The network helps show where Zhentong Wei may publish in the future.

Co-authorship network of co-authors of Zhentong Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Zhentong Wei. A scholar is included among the top collaborators of Zhentong Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhentong Wei. Zhentong Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jin, Yuchuan, Yiyang Jia, Shoujun Zhu, et al.. (2025). Fully synthetic nanofibrillar hydrogel for the growth and enzyme-free release of patient-derived ovarian tumor organoids. Biomaterials. 326. 123723–123723. 1 indexed citations
3.
Jia, Haiyan, Songling Zhang, Yuping Sun, et al.. (2024). Phase 1 study of BAT8006, a folate receptor α antibody drug conjugate with strong bystander effect, in subjects with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 5550–5550. 3 indexed citations
4.
5.
6.
Wei, Zhentong, et al.. (2023). The promoting effect and mechanism of Nrf2 on cell metastasis in cervical cancer. Journal of Translational Medicine. 21(1). 433–433. 10 indexed citations
7.
8.
Zhang, Mengwen, Danjie Li, Ning Ma, et al.. (2022). Nrf2 Signaling Pathway Mediates the Protective Effects of Daphnetin Against D-Galactose Induced-Premature Ovarian Failure. Frontiers in Pharmacology. 13. 810524–810524. 28 indexed citations
9.
Ma, Ning, et al.. (2021). Farrerol Ameliorated Cisplatin-Induced Chronic Kidney Disease Through Mitophagy Induction via Nrf2/PINK1 Pathway. Frontiers in Pharmacology. 12. 768700–768700. 42 indexed citations
10.
11.
Pang, Bo, et al.. (2021). Peritoneal well-differentiated papillary mesothelioma associated with infertility in a 37-year-old woman. Journal of International Medical Research. 49(1). 1220786232–1220786232.
12.
Wei, Zhentong, et al.. (2021). Ovarian microcystic stromal tumor with omental metastasis: the first case report and literature review. Journal of Ovarian Research. 14(1). 73–73. 8 indexed citations
13.
Li, Danjie, et al.. (2021). Diosmetin induces apoptosis in ovarian cancer cells by activating reactive oxygen species and inhibiting the Nrf2 pathway. Medical Oncology. 38(5). 54–54. 12 indexed citations
14.
Wei, Zhentong, et al.. (2021). Depiction of Vaginal Microbiota in Women With High-Risk Human Papillomavirus Infection. Frontiers in Public Health. 8. 587298–587298. 52 indexed citations
15.
Li, Siying, Zhentong Wei, Min Xie, et al.. (2019). Ubiquitination of the HPV Oncoprotein E6 Is Critical for E6/E6AP-Mediated p53 Degradation. Frontiers in Microbiology. 10. 2483–2483. 87 indexed citations
16.
Zhang, Nannan, Haoran Guo, Guanchen Liu, et al.. (2017). The poly-proline tail of SIVmac Vpx provides gain of function for resistance to a cryptic proteasome-dependent degradation pathway. Virology. 511. 23–29. 1 indexed citations
17.
Xu, Ying, Wenlong Zhang, Zhentong Wei, et al.. (2017). Irreversible electroporation in the eradication of rabbit VX2 cervical tumors. Biomedical Microdevices. 19(4). 90–90. 1 indexed citations
18.
Wei, Zhentong, et al.. (2017). Characteristics of primary side population cervical cancer cells. Oncology Letters. 14(3). 3536–3544. 7 indexed citations
19.
20.
Wang, Yishu, et al.. (2012). Isolation and characterization of cancer stem cells from cervical cancer HeLa cells. Cytotechnology. 64(4). 477–484. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhaojun Shen Breakdown of academic impact, for papers by Aki Yamashita Breakdown of academic impact, for papers by Mónica Mendoza-Rodríguez Breakdown of academic impact, for papers by Qiaoli Zheng Breakdown of academic impact, for papers by Bing Wei Breakdown of academic impact, for papers by Woong‐Shick Ahn Breakdown of academic impact, for papers by Shan‐Chih Lee Breakdown of academic impact, for papers by Manhua Cui Breakdown of academic impact, for papers by Zohreh Hojati Breakdown of academic impact, for papers by Buzhen Tan
Rankless by CCL
2026